Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

fresenius kabi d.o.o., radnička cesta 37a, zagreb, hrvatska - alanin arginin glicin histidin izoleucin leucin lizinacetat metionin fenilalanin prolin serin taurin treonin triptofan tirozin valin kalcijev klorid dihidrat natrijev glicerofosfat hidrat magnezijev sulfat heptahidrat kalijev klorid natrijev acetat trihidrat cinkov sulfat heptahidrat glukoza hidrat sojino ulje, rafinirano trigliceridi, srednje duljine lanca maslinovo ulje, rafinirano riblje ulje, obogaćeno omega-3 kiselinama - emulzija za infuziju - urbroj: 1026 ml emulzije sadrži 348 ml otopine aminokiselina + 478 ml otopine glukoze + 200 ml lipidne emulzije 1539 ml emulzije sadrži 522 ml otopine aminokiselina + 717 ml otopine glukoze + 300 ml lipidne emulzije 2052 ml emulzije sadrži 696 ml otopine aminokiselina + 956 ml otopine glukoze + 400 ml lipidne emulzije 2565 ml emulzije sadrži 870 ml otopine aminokiselina + 1195 ml otopine glukoze + 500 ml lipidne emulzije

Evropská unie - chorvatština - EMA (European Medicines Agency)

serb sa - betaine - homocistinuriju - drugi gastrointestinalni trakt i metabolizam, lijekovi, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:•         cystathionine beta-synthase (cbs),•         5,10 methylene tetrahydrofolate reductase (mthfr),•         cobalamin cofactor metabolism (cbl).

Evropská unie - chorvatština - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinom, ne-malih stanica pluća - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Evropská unie - chorvatština - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - neoplazme dojki - endokrinska terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Evropská unie - chorvatština - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Evropská unie - chorvatština - EMA (European Medicines Agency)

recordati rare diseases - karglumna kiselina - amino acid metabolism, inborn errors; propionic acidemia - drugi gastrointestinalni trakt i metabolizam, lijekovi, - carbaglu je indiciran u liječenju:hyperammonaemia komunikacije do n-acetylglutamate-sintaze primarni deficit;hyperammonaemia zbog изовалериановой acidaemia;hyperammonaemia zbog methymalonic acidaemia;hyperammonaemia zbog пропионовой acidaemia.

Evropská unie - chorvatština - EMA (European Medicines Agency)

merck sharp & dohme b.v. - efavirenz - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - stocrin je indiciran u antivirusnom kombiniranom tretmanu odraslih, adolescenata i djece starijih od tri godine starijih od ljudske imunodeficijencije-1 (hiv-1). Стокрин nisu bili pravilno istražena u bolesnika s uznapredovalom faze infekcije hiv-om, a upravo je u bolesnika s razinom cd4 < 50 ćelija/mm3, ili nakon neuspjeha протеаза-inhibitora (pi)-sadrže sheme. iako je cross-otpornost эфавиренза sa ip nije bio registriran, trenutno nema dovoljno podataka o efikasnosti kasniju upotrebu pi na temelju kombinirane terapije neučinkovitosti sheme sadrže Стокрин.

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - eritromicinestolat - kapsula, tvrda - 250 mg - urbroj: jedna kapsula sadrži 250 mg eritromicina u obliku eritromicinestolata

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

mip pharma croatia d.o.o., mihanovićeva 14, zagreb, hrvatska - klindamicinklorid - filmom obložena tableta - 300 mg - urbroj: jedna filmom obložena tableta sadrži 300 mg klindamicina u obliku klindamicinklorida

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

mip pharma croatia d.o.o., mihanovićeva 14, zagreb, hrvatska - klindamicinklorid - filmom obložena tableta - 600 mg - urbroj: jedna filmom obložena tableta sadrži 600 mg klindamicina u obliku klindamicinklorida